Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia J Simner

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Journal of Clinical Microbiology|April 7, 2017
Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among EnterobacteriaceaeVirginia M Pierce, Patricia J Simner, David R Lonsway, et al.
Journal of Clinical Microbiology|November 10, 2017
Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumanniiPatricia J Simner, J Kristie Johnson, William B Brasso, et al.
Journal of Clinical Microbiology|March 28, 2020
College of American Pathologists (CAP) Microbiology Committee Perspective: the Need for Verification StudiesChristina M Wojewoda, Neil W Anderson, Romney M Humphries, et al.
Antimicrobial Resistance and Infection Control|May 30, 2026
Environmental reservoirs of carbapenem-resistant organisms in the intensive care unit: a multicenter longitudinal study in two middle-income country hospitalsValeria Fabre, Mathew L Robinson, Florencia Martino, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2021
Guillain-Barré Syndrome Outbreak in Peru 2019 Associated With <i>Campylobacter jejuni</i> InfectionAna P Ramos, Sonja E Leonhard, Susan K Halstead, et al.
Journal of Clinical Microbiology|January 7, 2018
Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular AnalysisPreeti Pancholi, Karen C Carroll, Blake W Buchan, et al.
Immunity|June 1, 2022
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responsesJulia W Angkeow, Daniel R Monaco, Athena Chen, et al.
The Lancet. Infectious Diseases|August 10, 2020
STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studiesTehmina Bharucha, Clarissa Oeser, Francois Balloux, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2025
Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains isolated from respiratory and bloodstream sources: results from ACNBio studyEcem Buyukyanbolu, Jill Argotsinger, Eric T Beck, et al.
Microbiology Spectrum|March 23, 2026
Antimicrobial activity of sulbactam-durlobactam against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025)Elizabeth Cyr, Jill Argotsinger, Eric T Beck, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Journal of Clinical Microbiology|April 7, 2017
Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among EnterobacteriaceaeVirginia M Pierce, Patricia J Simner, David R Lonsway, et al.
Journal of Clinical Microbiology|November 10, 2017
Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumanniiPatricia J Simner, J Kristie Johnson, William B Brasso, et al.
Journal of Clinical Microbiology|March 28, 2020
College of American Pathologists (CAP) Microbiology Committee Perspective: the Need for Verification StudiesChristina M Wojewoda, Neil W Anderson, Romney M Humphries, et al.
Antimicrobial Resistance and Infection Control|May 30, 2026
Environmental reservoirs of carbapenem-resistant organisms in the intensive care unit: a multicenter longitudinal study in two middle-income country hospitalsValeria Fabre, Mathew L Robinson, Florencia Martino, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 6, 2021
Guillain-Barré Syndrome Outbreak in Peru 2019 Associated With <i>Campylobacter jejuni</i> InfectionAna P Ramos, Sonja E Leonhard, Susan K Halstead, et al.
Journal of Clinical Microbiology|January 7, 2018
Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular AnalysisPreeti Pancholi, Karen C Carroll, Blake W Buchan, et al.
Immunity|June 1, 2022
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responsesJulia W Angkeow, Daniel R Monaco, Athena Chen, et al.
The Lancet. Infectious Diseases|August 10, 2020
STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studiesTehmina Bharucha, Clarissa Oeser, Francois Balloux, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2025
Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains isolated from respiratory and bloodstream sources: results from ACNBio studyEcem Buyukyanbolu, Jill Argotsinger, Eric T Beck, et al.
Microbiology Spectrum|March 23, 2026
Antimicrobial activity of sulbactam-durlobactam against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains causing non-respiratory and non-bloodstream infections from the United States (2023-2025)Elizabeth Cyr, Jill Argotsinger, Eric T Beck, et al.
Pageof 16